HCW Biologics Inc (HCWB)
1.12
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
HCW Biologics Price to Book Value: 4.847 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 4.847 |
| June 13, 2024 | 4.834 |
| June 12, 2024 | 4.890 |
| June 11, 2024 | 4.630 |
| June 10, 2024 | 4.371 |
| June 07, 2024 | 4.502 |
| June 06, 2024 | 4.500 |
| June 05, 2024 | 4.554 |
| June 04, 2024 | 4.544 |
| June 03, 2024 | 4.717 |
| May 31, 2024 | 4.717 |
| May 30, 2024 | 4.717 |
| May 29, 2024 | 4.760 |
| May 28, 2024 | 4.760 |
| May 24, 2024 | 4.803 |
| May 23, 2024 | 4.760 |
| May 22, 2024 | 4.803 |
| May 21, 2024 | 4.785 |
| May 20, 2024 | 4.803 |
| May 17, 2024 | 4.760 |
| May 16, 2024 | 4.760 |
| May 15, 2024 | 5.020 |
| May 14, 2024 | 4.976 |
| May 13, 2024 | 4.847 |
| May 10, 2024 | 4.890 |
| Date | Value |
|---|---|
| May 09, 2024 | 5.193 |
| May 08, 2024 | 5.020 |
| May 07, 2024 | 5.539 |
| May 06, 2024 | 5.539 |
| May 03, 2024 | 5.755 |
| May 02, 2024 | 5.712 |
| May 01, 2024 | 5.958 |
| April 30, 2024 | 6.058 |
| April 29, 2024 | 6.102 |
| April 26, 2024 | 6.058 |
| April 25, 2024 | 6.318 |
| April 24, 2024 | 6.491 |
| April 23, 2024 | 6.939 |
| April 22, 2024 | 7.054 |
| April 19, 2024 | 6.621 |
| April 18, 2024 | 7.183 |
| April 17, 2024 | 6.880 |
| April 16, 2024 | 6.859 |
| April 15, 2024 | 7.010 |
| April 12, 2024 | 7.270 |
| April 11, 2024 | 6.664 |
| April 10, 2024 | 6.664 |
| April 09, 2024 | 6.924 |
| April 08, 2024 | 6.928 |
| April 05, 2024 | 6.928 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.074
Minimum
Mar 20 2023
7.270
Maximum
Apr 12 2024
2.357
Average
1.869
Median
Feb 03 2023
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.922 |
| AIM ImmunoTech Inc | 5.566 |
| IGC Pharma Inc | 2.939 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.806 |
Price to Book Value Related Metrics
| PS Ratio | 10.34 |
| PEG Ratio | -0.0283 |
| Price | 1.12 |
| Earnings Yield | -67.86% |
| Market Cap | 42.36M |
| PEGY Ratio | -0.0283 |